Literature DB >> 32816883

Parvovirus B19 infection masquerading as relapsed acute lymphoblastic leukaemia following haematopoietic stem cell transplantation.

Trisha Larkin1, Peng Li2, Biljana Horn3.   

Abstract

A 7-year-old boy presented with a constellation of bone pain, a skeletal lesion, and pancytopenia after undergoing allogeneic haematopoietic stem cell transplantation for recurrent acute B-cell lymphoblastic leukaemia. Investigations to rule out leukaemia recurrence were unremarkable. Due to presence of maturation arrest in erythropoiesis with giant pronormoblasts and aberrant intranuclear inclusions on a bone marrow aspirate, parvovirus B19 (PVB-19) staining was completed and confirmed the diagnosis of disseminated PVB-19. Though PVB-19 infection after solid organ transplantation was reported in the literature as early as 1986, acquired PVB-19 viremia presenting with a solitary bone lesion is a novel presentation in paediatrics. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer intervention; paediatrics; pathology

Mesh:

Year:  2020        PMID: 32816883      PMCID: PMC7437687          DOI: 10.1136/bcr-2020-235837

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Parvovirus B19 infection after transplantation: a review of 98 cases.

Authors:  Albert J Eid; Robert A Brown; Robin Patel; Raymund R Razonable
Journal:  Clin Infect Dis       Date:  2006-05-12       Impact factor: 9.079

2.  Parvovirus infection after renal transplant.

Authors:  G Neild; M Anderson; S Hawes; B T Colvin
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

3.  Parvovirus B19-Associated Anemia in Kidney Transplant Recipients: A Single-Center Experience.

Authors:  Ha Phan Hai An; Hoang Thi Diem; Nguyen The Cuong
Journal:  Transplant Proc       Date:  2019-07-24       Impact factor: 1.066

4.  The spectrum of parvovirus b19 infection in a pediatric hemato-oncologic ward.

Authors:  Herwig Lackner; Petra Sovinz; Martin Benesch; Stephan W Aberle; Wolfgang Schwinger; Sandrin Schmidt; Volker Strenger; Sonja Pliemitscher; Christian Urban
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

5.  Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.

Authors:  Jonathan R Kerr; Victoria S Cunniffe; Peter Kelleher; Andrew J S Coats; Derek L Mattey
Journal:  J Med Virol       Date:  2004-09       Impact factor: 2.327

6.  Bone lesions in an infant with congenital parvovirus b19 infection.

Authors:  Joseph B Cantey; Marcia A Pritchard; Pablo J Sánchez
Journal:  Pediatrics       Date:  2013-04-22       Impact factor: 7.124

7.  Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT.

Authors:  J Rahiala; M Koskenvuo; P Norja; M Meriluoto; M Toppinen; A Lahtinen; E Väisänen; M Waris; T Vuorinen; U Saarinen-Pihkala; M Lappalainen; T Allander; O Ruuskanen; K Hedman; M Söderlund-Venermo; K Vettenranta
Journal:  Bone Marrow Transplant       Date:  2013-05-20       Impact factor: 5.483

8.  Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Authors:  Lia Gore; Franco Locatelli; Gerhard Zugmaier; Rupert Handgretinger; Maureen M O'Brien; Peter Bader; Deepa Bhojwani; Paul-Gerhardt Schlegel; Catherine A Tuglus; Arend von Stackelberg
Journal:  Blood Cancer J       Date:  2018-08-22       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.